AzTrials
AzTrials

Low Back Pain, MechanicalHypermobleNCT02761928

Investigation of Hypermobility, Biomarkers, and Pain Generators in Chronic Pain Patients

An observational study of Low Back Pain, Mechanical and Spinal Stenosis, run by The University of Texas Health Science Center, Houston at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Observational study of axial spine pain and hyperflexibility. Patients will receive physical exam maneuvers (traditional straight leg raise, FABER, facet loading as well as Beighton's hypermobility score) and blood / urine / saliva collection. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Beighton score for hypermobility
Type of treatment
Injection or infusion
How many people
31 participants
Where
1 siteUnited States
Study dates
Jan 2016to 1 Aug 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients with low back pain who are determined to be candidates for a pain procedure

Who may be able to join

  • Clinical diagnosis of axial back pain (neck, mid-back, lower back) or pain radiating to the extremity, with suspected diagnosis of a specific pain generator amenable to a pain procedure, including disorders of the nerves, joints, and muscles as listed immediately below.
  • Clinical decision to schedule patient for a pain procedure, including procedures targeting the following disorders:
  • Facet arthropathy: intra-articular facet joint injection, medial branch block, medial branch radiofrequency ablation
  • Sacroiliac joint dysfunction: sacroiliac joint injection, lateral branch block, lateral branch radiofrequency ablation
  • Myofascial pain syndrome: trigger point injection
  • Radiculopathy, spinal stenosis, or herniated nucleus pulposus: epidural steroid injection, selective nerve root block
Show all 9Show fewer
  • Piriformis syndrome: piriformis injection
  • Greater trochanteric bursitis: greater trochanteric bursa injection
  • Able to provide HIPAA authorization to share prior medical records/imaging.

Who cannot join

  • Previous diagnosis of cancer.
  • Currently pregnant.
  • Previously enrolled for the same procedure or the same pain generator site. (For example, this would exclude a patient who had an intra-articular facet joint injection at the right L5/S1 if: 1) he had the same injection 3 months ago and was enrolled at that time, or 2) the patient was already enrolled for a medial branch block at the right L5 and sacral ala, as this targets the same facet joint.)
  • Inability or unwillingness of subject or legal guardian/representative to give informed consent (e.g., ward of the state)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Texas Health Science Center at Houston

    Houston, Texas, 77030

Other trials in United States

About this study

Observational study of axial spine pain and hyperflexibility. Patients will receive physical exam maneuvers (traditional straight leg raise, FABER, facet loading as well as Beighton's hypermobility score) and blood / urine / saliva collection. They will also be separated into pain groups based on their response to injections. A correlation between exam findings and procedure group will be measured.

Read the detailed description

This is an observational study of patients with neck and back pain followed by a pain management clinic. Patients with particular pain generators in the neck and back will be defined by a positive response to one of several targeted interventional pain procedures. Each patient may undergo a physical exam to determine whether they have hypermobile joints. The study will thus evaluate the rate of hypermobility for each pain generator. In addition blood, urine, or saliva samples may be taken for biomarkers for pain or rheumatologic factors.

Being tested
Beighton score for hypermobility
Keywords
Facet Joint, Sacroiliac Joint, Myofascial Trigger Point Pain, Injectables
Medical subject headings
Low Back Pain, Spinal Stenosis, Radiculopathy, Ehlers-Danlos syndrome type 3, Myofascial Pain Syndromes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Beighton score for hypermobilityOther

    The beighton score is a 9 point score of flexibility, used for patients with disorders of collagen.

Study groups in NCT02761928
Study groupRoleWhat they receive
EpiduralPositive response (>50% pain relief) to any epidural (e.g. interlaminar/paramedian, transforaminal, caudal)
Receives: Other: Beighton score for hypermobility
Selective nerve root blockPositive response (>50% pain relief) to selective nerve root block
Receives: Other: Beighton score for hypermobility
Facet injectionPositive response (>50% pain relief) to intra-articular facet injection
Receives: Other: Beighton score for hypermobility
Medial branch blockPositive response (>50% pain relief) to median branch nerve block
Receives: Other: Beighton score for hypermobility
Medial branch RFAPositive response (>50% pain relief) to median branch nerve radiofrequency ablation
Receives: Other: Beighton score for hypermobility
SIJ injectionPositive response (>50% pain relief) to sacroiliac joint injection
Receives: Other: Beighton score for hypermobility
Lateral branch blockPositive response (>50% pain relief) to lateral branch nerve block for SIJ
Receives: Other: Beighton score for hypermobility
Greater trochanter injectionPositive response (>50% pain relief) to greater trochanteric bursa injection
Receives: Other: Beighton score for hypermobility
Piriformis injectionPositive response (>50% pain relief) to piriformis injection
Receives: Other: Beighton score for hypermobility
Trigger point injectionPositive response (>50% pain relief) to trigger point injection
Receives: Other: Beighton score for hypermobility

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Beighton hypermobility score

    9 point standardized scale

    Measured: Prior to injection (2 weeks prior to injection for each patient)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 May 2016 (estimated)
  2. Study startJan 2016
  3. Primary completion1 Aug 2017
  4. Study completion1 Aug 2017

Why it stopped: Insufficient enrollment, lack of funding to continue

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
31 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02761928
Sponsor's protocol ID
HSC-MS-15-0809
Acronym
Hypermoble
Status last verified
Nov 2020
First submitted
24 Apr 2016
Last updated
12 Nov 2020
Results posted
No
Data monitoring committee
No

Publications

  • Grahame R. Joint hypermobility syndrome pain. Curr Pain Headache Rep. 2009 Dec;13(6):427-33. doi: 10.1007/s11916-009-0070-5.

    PubMed 19889283

Questions about this trial

What is this clinical trial studying?

An observational study of Low Back Pain, Mechanical and Spinal Stenosis, run by The University of Texas Health Science Center, Houston at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 12 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Insufficient enrollment, lack of funding to continue). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Beighton hypermobility score (time frame: Prior to injection (2 weeks prior to injection for each patient)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02761928, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Nov 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in